Orthopediatrics (NASDAQ:KIDS) Stock Rating Lowered by BidaskClub

BidaskClub downgraded shares of Orthopediatrics (NASDAQ:KIDS) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning, BidAskClub reports.

A number of other analysts also recently weighed in on the company. Needham & Company LLC set a $69.00 price target on Genomic Health and gave the company a buy rating in a research note on Wednesday, June 19th. Zacks Investment Research downgraded Hess Midstream Partners from a hold rating to a sell rating in a research note on Tuesday, May 14th. Finally, BTIG Research decreased their price target on Verastem to $8.00 and set a buy rating on the stock in a research note on Friday, May 10th. Two equities research analysts have rated the stock with a sell rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus price target of $46.75.

Shares of KIDS stock opened at $35.00 on Tuesday. The company has a 50 day moving average of $39.56. Orthopediatrics has a twelve month low of $25.11 and a twelve month high of $47.82. The company has a current ratio of 8.60, a quick ratio of 6.01 and a debt-to-equity ratio of 0.26.

Orthopediatrics (NASDAQ:KIDS) last announced its earnings results on Wednesday, May 8th. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.04). Orthopediatrics had a negative net margin of 16.71% and a negative return on equity of 16.43%. The company had revenue of $14.66 million during the quarter, compared to analysts’ expectations of $14.67 million. On average, equities analysts expect that Orthopediatrics will post -0.45 EPS for the current year.

Several institutional investors have recently bought and sold shares of KIDS. RTW Investments LP purchased a new stake in shares of Orthopediatrics in the fourth quarter valued at approximately $7,848,000. Prospect Capital Advisors LLC acquired a new position in shares of Orthopediatrics in the fourth quarter worth $7,136,000. American Century Companies Inc. acquired a new position in shares of Orthopediatrics in the fourth quarter worth $3,880,000. BlackRock Inc. raised its holdings in shares of Orthopediatrics by 12.4% in the fourth quarter. BlackRock Inc. now owns 455,657 shares of the company’s stock worth $15,894,000 after acquiring an additional 50,179 shares during the last quarter. Finally, FMR LLC raised its holdings in shares of Orthopediatrics by 8.6% in the fourth quarter. FMR LLC now owns 414,600 shares of the company’s stock worth $14,462,000 after acquiring an additional 33,000 shares during the last quarter. Hedge funds and other institutional investors own 48.67% of the company’s stock.

About Orthopediatrics

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.

Featured Story: Average Daily Trade Volume – ADTV

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.